in AD.—Esther Landhuis. References: Chen P-C, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA.
receptor antagonists.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1879 Alzheimer's
on self-aggregating cleaved tau fragments (see ARF related conference story).—Esther Landhuis None
may point to a novel therapeutic strategy that has not yet been considered.”—Esther Landhuis None
is no reasonable time when I could predict it will be over.”—Esther Landhuis and Gabrielle Strobel. None
holds up in older people (age 65 and up) lacking overt memory problems.—Esther Landhuis None
of the study,” she said.—Esther Landhuis. This is Part 1 of a two-part series. See also Part 2. None
ADNI2 participants will get ASL as part of their MRI scan.—Esther Landhuis None
story; Gandy et al., 2010).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2439
C-terminus—which binds Fe65 and other cytoplasmic proteins—could still mediate key APP functions.—Esther Landhuis.
in the management of AD risk factors, and general advances in medical care for older people, Jones noted.—Esther
re-evaluating that decision.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2659
and geranylgeranylation.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1874 Aging Sirtuins
abstracts.—Esther Landhuis. This is Part 1 of a three-part series. See also Parts 2 and 3. None
their brains are too damaged to be repaired.”—Esther Landhuis. This is Part 2 of a two-part series. See Part 1.